Details for New Drug Application (NDA): 018701
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
The generic ingredient in HALDOL is haloperidol. There are twenty drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the haloperidol profile page.
Summary for 018701
Tradename: | HALDOL |
Applicant: | Janssen Pharms |
Ingredient: | haloperidol decanoate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 018701
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
HALDOL | haloperidol decanoate | INJECTABLE;INJECTION | 018701 | NDA AUTHORIZED GENERIC | Patriot Pharmaceuticals LLC | 10147-0921 | 10147-0921-3 | 3 AMPULE in 1 BOX (10147-0921-3) / 1 mL in 1 AMPULE |
HALDOL | haloperidol decanoate | INJECTABLE;INJECTION | 018701 | NDA AUTHORIZED GENERIC | Patriot Pharmaceuticals LLC | 10147-0922 | 10147-0922-5 | 5 AMPULE in 1 BOX (10147-0922-5) / 1 mL in 1 AMPULE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 50MG BASE/ML | ||||
Approval Date: | Jan 14, 1986 | TE: | AO | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 100MG BASE/ML | ||||
Approval Date: | Jan 31, 1997 | TE: | AO | RLD: | Yes |
Complete Access Available with Subscription